null

NRF2 Rabbit Polyclonal Antibody (CAB1244)

SKU:
CAB1244
Product Type:
Antibody
Reactivity:
Human
Mouse
Rat
Host Species:
Rabbit
Isotype:
IgG
Antibody Type:
Polyclonal Antibody
Research Area:
Immunology
  • Immunology Antibodies 1 Anti-NRF2 Antibody CAB1244
  • Immunology Antibodies 1 Anti-NRF2 Antibody CAB1244
  • Immunology Antibodies 1 Anti-NRF2 Antibody CAB1244
  • Immunology Antibodies 1 Anti-NRF2 Antibody CAB1244
  • Immunology Antibodies 1 Anti-NRF2 Antibody CAB1244
€139 - €419
Frequently bought together:

Description

system_update_altDatasheetsystem_update_altMSDS

NRF2 Rabbit Polyclonal Antibody (CAB1244)

The NFE2L2 Polyclonal Antibody (CAB1244) is specifically designed for research involving NFE2L2, a transcription factor that plays a key role in the regulation of antioxidant response element (ARE) genes. The antibody, raised in rabbits, is highly reactive with human samples and has been validated for use in various applications, including Western blot and immunohistochemistry. By binding to NFE2L2 protein, this antibody enables accurate detection and analysis in multiple cell types, making it an essential tool for studies in oxidative stress, inflammation, and cancer research.NFE2L2, also known as nuclear factor erythroid 2-related factor 2, is a crucial regulator of cellular defense mechanisms against oxidative stress and inflammation. Its involvement in the activation of antioxidant and detoxification genes makes it a central player in maintaining cellular homeostasis and protecting cells from damage.

Research on NFE2L2 is particularly important for understanding diseases associated with oxidative stress, such as neurodegenerative disorders, cardiovascular diseases, and cancer.By using the NFE2L2 Polyclonal Antibody (CAB1244), researchers can gain valuable insights into the molecular mechanisms underlying NFE2L2 activation and its impact on cellular responses to oxidative stress. This antibody is an indispensable tool for investigating the role of NFE2L2 in various physiological and pathological conditions, paving the way for the development of novel therapeutic strategies targeting NFE2L2 signaling